Stock Yards Bank & Trust CO Gilead Sciences, Inc. Transaction History

Stock Yards Bank & Trust CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	SELL	$63.15 - $72.88 $15,850 - $18,292	-251 Reduced 7.35%	3,162 $216,000
Q1 2024 Apr 29, 2024	BUY	$71.58 - $87.29 $18,109 - $22,084	253 Added 8.01%	3,413 $250,000
Q4 2023 Feb 01, 2024	SELL	$73.27 - $83.09 $5,495 - $6,231	-75 Reduced 2.32%	3,160 $255,000
Q3 2023 Nov 01, 2023	SELL	$73.94 - $80.67 $45,325 - $49,450	-613 Reduced 15.93%	3,235 $242,000
Q2 2023 Aug 02, 2023	SELL	$76.01 - $86.7 $61,416 - $70,053	-808 Reduced 17.35%	3,848 $296,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $10,204 - $11,626	-132 Reduced 2.76%	4,656 $387,000
Q4 2022 Feb 02, 2023	BUY	$62.32 - $89.47 $16,951 - $24,335	272 Added 6.02%	4,788 $411,000
Q3 2022 Nov 03, 2022	SELL	$59.54 - $68.01 $8,931 - $10,201	-150 Reduced 3.21%	4,516 $279,000
Q2 2022 Aug 24, 2022	BUY	$57.72 - $65.01 $269,321 - $303,336	4,666 New	4,666 $289,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Stock Yards Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Stock Yards Bank & Trust CO with notifications on news.